Schizophrenia for primary care providers: How to contribute to the care of a vulnerable patient population

American Journal of Medicine

Volumn 125, Issue 3, 2012, Pages 223-230

  Viron, Mark ^a   Baggett, Travis ^a   Hill, Michele ^a   Freudenreich, Oliver ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cardiovascular disease; Management; Medical morbidity; Primary care; Schizophrenia; Treatment

Indexed keywords

ARIPIPRAZOLE; ASENAPINE; CHLORPROMAZINE; CLOZAPINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; ILOPERIDONE; LURASIDONE; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

AGRANULOCYTOSIS; ANTICHOLINERGIC EFFECT; BEHAVIOR THERAPY; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL PRACTICE; COGNITIVE DEFECT; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DISEASE SEVERITY; DRUG WITHDRAWAL; DYSTONIA; ENDOCRINE DISEASE; EXTRAPYRAMIDAL SYMPTOM; GASTROINTESTINAL DISEASE; GENERAL PRACTITIONER; GLUCOSE METABOLISM; HEALTH DISPARITY; HUMAN; INFECTION; LIFESTYLE MODIFICATION; LIPID METABOLISM; MEDICAL ASSESSMENT; MENTAL HEALTH CARE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NEGATIVE SYNDROME; PATIENT CARE; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PSYCHOMETRY; PSYCHOSIS; PSYCHOTHERAPY; RELAPSE; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; SUICIDE; TARDIVE DYSKINESIA; VULNERABLE POPULATION;

CARDIOVASCULAR DISEASES; DIAGNOSIS, DIFFERENTIAL; HEALTH SERVICES NEEDS AND DEMAND; HEALTHCARE DISPARITIES; HUMANS; MONITORING, PHYSIOLOGIC; PRIMARY HEALTH CARE; SCHIZOPHRENIA; VULNERABLE POPULATIONS;

EID: 84857215960     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.05.002     Document Type: Review

References (58)

1. J. McGrath, S. Saha, D. Chant, J. Welham Schizophrenia: a concise overview of incidence, prevalence, and mortality Epidemiol Rev 30 2008 67 76
2. L.P. Henry, G.P. Amminger, M.G. Harris The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission J Clin Psychiatry 71 2010 716 728
3. M.J. Viron, T.A. Stern The impact of serious mental illness on health and healthcare Psychosomatics 51 2010 458 465
4. K.J. Gold, A.M. Kilbourne, M. Valenstein Primary care of patients with serious mental illness: your chance to make a difference J Fam Pract 57 2008 515 525
5. C.W. Colton, R.W. Manderscheid Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states Prev Chronic Dis 3 2006 1 14
6. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR 4th ed. 2000 American Psychiatric Association Washington, DC
7. O. Freudenreich, S.C. Schulz, D.C. Goff Initial medical work-up of first-episode psychosis: a conceptual review Early Interv Psychiatry 3 2009 10 18
8. American Psychiatric Association Proposed draft revisions to DSM disorders and criteria 2011 http://www.dsm5.org/ProposedRevisions/Pages/ proposedrevision.aspx?rid=411 Accessed April 6, 2011
9. O. Freudenreich Schizophrenia? Target 6 symptom clusters Curr Psychiatr 8 2009 74
10. G. Foussias, G. Remington Negative symptoms in schizophrenia: avolition and Occam's razor Schizophr Bull 36 2010 359 369
11. B.W. Palmer, S.E. Dawes, R.K. Heaton What do we know about neuropsychological aspects of schizophrenia? Neuropsychol Rev 19 2009 365 384
12. V. Peralta, M.S. Campos, E.G. De Jalon, M.J. Cuesta Motor behavior abnormalities in drug-naive patients with schizophrenia spectrum disorders Mov Disord 25 2010 1068 1076
13. D.J. Carlat The Psychiatric Interview: A Practical Guide 2nd ed. 2005 Lippincott Williams & Wilkins Philadelphia 190 209
14. A.C. Brodkey, K. Van Zant, F.S. Sierles Educational objectives for a junior psychiatry clerkship: development and rationale Acad Psychiatry 21 1997 179 204
15. P.E. Bebbington, T. Nayani The psychosis screening questionnaire Int J Methods Psychiatr Res 5 1995 11 19
16. K. Salimi, L.F. Jarskog, J.A. Lieberman Antipsychotic drugs for first-episode schizophrenia: a comparative review CNS Drugs 23 2009 837 855
17. S.M. Stahl, L. Mignon, J.M. Meyer Which comes first: atypical antipsychotic treatment or cardiometabolic risk? Acta Psychiatr Scand 119 2009 171 179
18. M. Hasnain, S.K. Fredrickson, W.V. Vieweg, A.K. Pandurangi Metabolic syndrome associated with schizophrenia and atypical antipsychotics Curr Diab Rep 10 2010 209 216
19. ADA APA AACE NAASO Consensus development conference on antipsychotic drugs and obesity and diabetes Diabetes Care 27 2004 596 601
20. A. Nussbaum, T.S. Stroup Paliperidone for schizophrenia Cochrane Database Syst Rev 2008 CD006369
21. L. Citrome Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic Int J Clin Pract 63 2009 1762 1784
22. S. Caccia, L. Pasina, A. Nobili New atypical antipsychotics for schizophrenia: iloperidone Drug Des Devel Ther 4 2010 33 48
23. L. Citrome Lurasidone for schizophrenia: a brief review of a new second-generation antipsychotic Clin Schizophr Relat Psychoses 4 2011 251 257
24. J.A. Lieberman, T.S. Stroup, J.P. McEvoy Effectiveness of antipsychotic drugs in patients with chronic schizophrenia N Engl J Med 353 2005 1209 1223
25. C. Asenjo Lobos, K. Komossa, C. Rummel-Kluge Clozapine versus other atypical antipsychotics for schizophrenia Cochrane Database Syst Rev 11 2010 CD006633
26. C.U. Correll Balancing efficacy and safety in treatment with antipsychotics CNS Spectr 12 10 Suppl 17 2007 12 20 35
27. S. Brown, M. Kim, C. Mitchell, H. Inskip Twenty-five year mortality of a community cohort with schizophrenia Br J Psychiatry 196 2010 116 121
28. S. Saha, D. Chant, J. McGrath A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 64 2007 1123 1131
29. E.C. Harris, B. Barraclough Excess mortality of mental disorder Br J Psychiatry 173 1998 11 53
30. B.A. Palmer, V.S. Pankratz, J.M. Bostwick The lifetime risk of suicide in schizophrenia: a reexamination Arch Gen Psychiatry 62 2005 247 253
31. J.B. Luoma, C.E. Martin, J.L. Pearson Contact with mental health and primary care providers before suicide: a review of the evidence Am J Psychiatry 159 2002 909 916
32. J. Stovall, F.J. Domino Approaching the suicidal patient Am Fam Physician 68 2003 1814 1818
33. U. Osby, N. Correia, L. Brandt, A. Ekbom, P. Sparn Mortality and causes of death in schizophrenia in Stockholm county, Sweden Schizophr Res 45 2000 21 28
34. T.M. Laursen, T. Munk-Olsen, E. Agerbo, C. Gasse, P.B. Mortensen Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder Arch Gen Psychiatry 66 2009 713 720
35. J.P. McEvoy, J.M. Meyer, D.C. Goff Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III Schizophr Res 80 2005 19 32
36. N.E. Morden, L.A. Mistler, W.B. Weeks, S.J. Bartels Health care for patients with serious mental illness: family medicine's role J Am Board Fam Med 22 2009 187 195
37. D.C. Goff, C. Cather, A.E. Evins Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists J Clin Psychiatry 66 2005 183 194 quiz 147, 273-184
38. S.R. Marder, S.M. Essock, A.L. Miller Physical health monitoring of patients with schizophrenia Am J Psychiatry 161 2004 1334 1349
39. J.A. Lieberman, D. Merrill, S. Parameswaran American Psychiatric Association (APA) guidance on the use of antipsychotic drugs and cardiac sudden death 2009 http://www.omh.state.ny.us/omhweb/advisories/adult-antipsychotic-use- attachement.html Accessed April 11, 2011
40. A.J. Wheeler, J. Harrison, P. Mohini, J. Nardan, A. Tsai, E. Tsai Cardiovascular risk assessment and management in mental health clients: whose role is it anyway? Community Ment Health J 46 2010 531 539
41. A. Mukundan, G. Faulkner, T. Cohn, G. Remington Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems Cochrane Database Syst Rev 12 2010 CD006629
42. J. Addington, N. El-Guebaly, D. Addington, D. Hodgins Readiness to stop smoking in schizophrenia Can J Psychiatry 42 1997 49 52
43. S.A. Schroeder A 51-year-old woman with bipolar disorder who wants to quit smoking JAMA 301 2009 522 531
44. S. Brown, J. Birtwistle, L. Roe, C. Thompson The unhealthy lifestyle of people with schizophrenia Psychol Med 29 1999 697 701
45. L.J. Cabassa, J.M. Ezell, R. Lewis-Fernandez Lifestyle interventions for adults with serious mental illness: a systematic literature review Psychiatr Serv 61 2010 774 782
46. L. Maayan, J. Vakhrusheva, C.U. Correll Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis Neuropsychopharmacology 35 2010 1520 1530
47. T.J.R. Lambert, J.W. Newcomer Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care Med J Aust 190 4 Suppl 2009 S39 S42
48. D.A. Regier, M.E. Farmer, D.S. Rae Comorbidity of mental disorders with alcohol and other drug abuse JAMA 264 1990 2511 2518
49. S.L. Batki, Z.S. Meszaros, K. Strutynski Medical comorbidity in patients with schizophrenia and alcohol dependence Schizophr Res 107 2009 139 146
50. V.J. Carr, T.J. Lewin, R.E. Barnard Attitudes and roles of general practitioners in the treatment of schizophrenia compared with community mental health staff and patients Soc Psychiatry Psychiatr Epidemiol 39 2004 78 84
51. H. Lester, J.Q. Tritter, H. Sorohan Patients' and health professionals' views on primary care for people with serious mental illness: focus group study BMJ 330 2005 1122 1127
52. A. Ucok, H. Soygur, C. Atakli The impact of antistigma education on the attitudes of general practitioners regarding schizophrenia Psychiatry Clin Neurosci 60 2006 439 443
53. S. Jones, L. Howard, G. Thornicroft 'Diagnostic overshadowing': worse physical health care for people with mental illness Acta Psychiatr Scand 118 2008 169 171
54. National Alliance on Mental Illness (NAMI) Schizophrenia: Public Attitudes, Personal Needs-Views from People Living with Schizophrenia, Caregivers, and the General Public 2008 NAMI Arlington, VA
55. Disability Rights Commission (UK) Equal Treatment: Closing the Gap Part 1 of the DRC's Formal Investigation Report 2006 DRC London
56. B.G. Druss, S.A. von Esenwein, M.T. Compton, K.J. Rask, L. Zhao, R.M. Parker A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study Am J Psychiatry 167 2010 151 159
57. B.G. Druss, S.A. Von Esenwein Improving general medical care for persons with mental and addictive disorders: systematic review Gen Hosp Psychiatry 28 2006 145 153
58. C. Collins, D. Levis Hewson, R. Munger, T. Wade Evolving Models of Behavioral Health Integration in Primary Care 2010 Milbank Memorial Fund New York